Hjem › Tripelnegativ brystkreft › New York › Buffalo
Kliniske studier for Tripelnegativ brystkreft i Buffalo, NY
7 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Buffalo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Intratumoral N17350 in Advanced Solid Tumors
RekruttererFase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RekruttererFase 2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Roswell Park Cancer Institute, Buffalo
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Buffalo
- Ikke-småcellet lungekreft19 studier
- Kreft (alle typer)19 studier
- Akut myelogen leukemi19 studier
- Lungekreft16 studier
- Brystkreft16 studier
- Eggstokkreft13 studier
- Metastatisk kreft11 studier
- Prostatakreft11 studier
- Melanom10 studier
- Multipelt myelom10 studier
- Fedme9 studier
- Burkitts lymfom8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.